Previous 10 | Next 10 |
home / stock / chyhy / chyhy news
2023-06-02 05:36:23 ET Summary Danish companies Novozymes and Christian Hansen have announced plans to merge, creating a leading global biosolutions company. The merger is expected to be completed in late 2023 or early 2024, following regulatory approval. Despite the wide econ...
Summary Novozymes is a Danish company that produces industrial enzymes, often used to replace chemicals in products and industrial processes. The company's products have a wide range of applications in household care, food and beverage, bio-energy, agriculture, feed, and even pharmaceut...
RPM International had an interesting fiscal year that it just reported financial results for. RPM's sales continued to climb, but some profitability metrics could have been better. The future is looking brighter, but there is some uncertainty about what the picture looks like beyo...
Seres' $100 million share placement with strategic partners, including Nestle, helps stabilize the share price. The C. difficile market - how big is it? Who can compete with the Seres/Nestle (Aimmune Therapeutics) global rollout for C. difficile recurrence? Seres has had two share...
Chr. Hansen has a wide competitive moat that allows it to earn good profit margins and maintain significant pricing power. The company operates in several attractive markets and has the potential to grow at a decent pace. Unfortunately, the valuation remains high, even despite a r...
Chr. Hansen is a great business and has a wide economic moat around its business. In the last few years, Chr. Hansen was rather struggling. Despite the share price dropping, it is still overvalued in my opinion. For further details see: Chr. Hansen: A Great Business, But...
Chr. Hansen Holding A/S (CHYHY) Q2 2022 Earnings Conference Call April 6 2022, 04:00 AM ET Company Participants Mauricio Graber - President and CEO Lise Mortensen - CFO Conference Call Participants Alexander Sloane - Barclays Christian Ryom - Nordea Markets Soren Samsoe - SEB Lars Topholm - C...
The following slide deck was published by Chr. Hansen Holding A/S in conjunction with their 2022 Q2 earnings call. For further details see: Chr. Hansen Holding A/S 2022 Q2 - Results - Earnings Call Presentation
March was a busy month for the portfolio. I sold my stake in South Jersey Industries, as it is being acquired, and that freed up money for more purchases than usual in March. Consumer staples, luxury goods companies, and Dividend Aristocrats were among the items on my shopping lis...
Seres misses on earnings and revenue, although revenue was up 344% to $144.92 million. Net loss of $50.00 million in Q4 compared with $18.3 million in Q4 2020, due significantly to preparing for launch of SER-109. Key publication on SER-109 C.difficile results and signs remain goo...
News, Short Squeeze, Breakout and More Instantly...
CHR Hansen Holding A/S ADR Company Name:
CHYHY Stock Symbol:
OTCMKTS Market:
CHICAGO , July 28, 2020 /PRNewswire/ -- Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingred...